Amino acids in diet could be key to starving cancer

April 19, 2017
Credit: CC0 Public Domain

Cutting out certain amino acids—the building blocks of proteins—from the diet of mice slows tumour growth and prolongs survival, according to new research published in Nature.

Researchers at the Cancer Research UK Beatson Institute and the University of Glasgow found that removing two non-essential —serine and glycine—from the diet of mice slowed the development of lymphoma and intestinal .

The researchers also found that the special diet made some cancer cells more susceptible to chemicals in cells called reactive oxygen species.

Chemotherapy and radiotherapy boost levels of these chemicals in the cells, so this research suggests a specially formulated diet could make conventional cancer treatments more effective.

The next stage would be to set up clinical trials with cancer patients to assess the feasibility and safety of such a treatment.

Dr Oliver Maddocks, a Cancer Research UK scientist at the University of Glasgow, said: "Our findings suggest that restricting specific amino acids through a controlled diet plan could be an additional part of treatment for some cancer patients in future, helping to make other treatments more effective.

Professor Karen Vousden, Cancer Research UK's chief scientist and study co-author said: "This kind of restricted diet would be a short term measure and must be carefully controlled and monitored by doctors for safety. Our diet is complex and protein—the main source of all amino acids - is vital for our health and well-being. This means that patients cannot safely cut out these specific amino acids simply by following some form of home-made diet."

Amino acids are the that cells need to make proteins. While healthy cells are able to make sufficient serine and glycine, cancer are much more dependent on getting these vital amino acids from the diet.

However, the study also found that the diet was less effective in tumours with an activated Kras gene, such as most pancreatic cancer, because the faulty gene boosted the ability of the to make their own serine and glycine. This could help to select which tumours could be best targeted by diet therapy.

Dr Emma Smith, science communication manager at Cancer Research UK, said: "This is a really interesting look at how cutting off the supply of nutrients essential to cancer cell growth and division could help restrain tumours.

"The next steps are clinical trials in people to see if giving a specialised that lacks these amino acids is safe and helps slow as seen in mice. We'd also need to work out which patients are most likely to benefit, depending on the characteristics of their cancer."

Explore further: Researchers find out what cancer cells are hungry for

More information: Modulating the therapeutic response of tumours to dietary serine and glycine starvation, Nature (2017). nature.com/articles/doi:10.1038/nature22056

Related Stories

Researchers find out what cancer cells are hungry for

February 15, 2016
Growing tumour cells are always hungry. Researchers of prof. Reuven Agami's group at the Antoni van Leeuwenhoek have developed a method that uncovers for individual tumours which amino acid is most limiting an thus most needed ...

Starving pancreatic cancer cells: Scientists identify potential pancreatic cancer target

October 17, 2016
Researchers have found that a protein called SLC6A14 is overexpressed by several fold in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue or normal pancreatic ...

Cancer cells grow by exploiting their neighbours

January 25, 2017
Researchers at the University of Oslo and Oslo University Hospital have discovered that cancer cells grow by stealing energy from neighbouring cells.

Study shows starving cancer cells of key nutrient slows tumour growth

December 18, 2012
Depriving cancer cells of a key amino acid dramatically cuts their ability to grow and multiply, according to a new Cancer Research UK study published in Nature.

Withholding amino acid depletes blood stem cells, researchers say

October 20, 2016
A dietary approach to depleting blood stem cells may make it possible to conduct bone marrow transplantations without the use of chemotherapy or radiation therapy, according to researchers at the Stanford University School ...

Recommended for you

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

Testing the accuracy of FDA-approved and lab-developed cancer genetics tests

December 14, 2017
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug. Clinical tests for common cancer causing-mutations in the genes ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.